Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings

Fig. 4

Cost-effectiveness acceptability frontier showing the probability that inhaled oxytocin is cost-effective for different willingness to pay thresholds in Ethiopia. Willingness to pay is shown in terms of USD per maternal life years saved (solid line) or maternal and child life years saved (dashed line). a The base case analysis, where all implementation costs are included. b Only ongoing costs are included in the analysis. A 3% discount rate was used. Dashed vertical lines represent 25%, 50% and 1 GDP per capita. GDP, gross domestic product

Back to article page